• Follow us
  • EN
    Flag Indonesia ID
    Flag English EN
Untitled design (6)
  • About Us
    • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Recruitment
  • PPID
  • Contact Us
search

HOW TO PREVENT INFLUENZA?

Friday, 8 January 2021

HOW TO PREVENT INFLUENZA?

Wash hands, cover nose and mouth when sneezing with a tissue, use a mask.

  • Surveillance

Conducted by the Ministry of Health to monitor circulating influenza viruses

  • Antivirus therapy

Can be as a therapy or prevention. Unfortunately not widely available at pharmacies

  • Vaccination

Influenza vaccination is the best way to prevent influenza. Vaccination is given once a year. Provides optimal protection after 28 days of injection. (autocount)

  • Injection requirements
  • No high fever
  • No egg / chicken protein allergy
  • No allergic reaction after injecting a flu vaccine in the past
  • Vial vaccines must be shaken to homogenize the suspension

Prevent seasonal influenza, for Indonesia which is a tropical country on the peak occurrence around the rainy season

Influenza vaccination decreases
1. Influenza like illness (ILI) incidence of 34%

2. The risk of ILI is fivefold

3. ISPA EC fever incidence (40.6% to 28.7%)

4. ILI rate attack (30.31% 8.13%)

5. Illness periode (5.8 days 5.37 days)

6. Effectively prevent hospitalizations up to 50-65% and deaths up to 80% in elderly patients & reduce the death rate of COPD patients 7.8

 

Benefits for Companies & Institutions :

Increasing Productivity of Companies & Institutions

Influenza vaccination decreases:

- 42% doctor visits

- sick leave of 32% 1 (from 21.1% à 9.9%), periode of leave (4.22 days à 3 days)

Cost Effectiveness Compared to oseltamivir antiviral therapy

 - Save up to USD 25 per person

Analysis of benefit costs1

- Save AUD 20.93 / worker / semester

Influenza Like Illness (ILI) incident

- Save AUD 139.61 / worker / semester

Output of Febrile Illness (fever)

- Save AUD 58.36 / worker

 

 

Reducing the occurrence of bacterial resistance due to the use of antibiotics from the treatment of influenza symptoms

Recommended for pilgrims of Hajj & Umrah

"The Ministry of Health recommends that all pilgrims from both inside and outside of the Kingdom of Saudi Arabia have their journey, especially those most vulnerable to complications from the flu, such as the elderly and people with chronic respiratory diseases, diabetes, and renal, liver and cardiac problems. "

The American Society of Internal Medicine in Atlanta, USA in 2010 reaffirmed that immunization in adults can prevent death by 100x compared to children.

In the 2010 public health program, the United States launched 60% of influenza vaccination in adults

Influenza vaccination will reduce the risk of co-infection and genetic reassortment of the human influenza (H1N1) and avian influenza (H5N1) viruses in birds in the human body,  thus preventing the formation of a new type of more virulent influenza virus.

 

  • Share to:
Download

Latest News

WhatsApp-Image-2018-08-06-at-13.13.46
Friday, 8 January 2021
10 explanations for the halal certification process regarding MR (Measles and Rubella) vaccines
5-HAL-TENTANG-VAKSIN-MR
Friday, 8 January 2021
5 HAL PENTING MENGENAI VAKSIN MR
FAQ-1-1
Friday, 8 January 2021
20 Fakta Tentang Vaksin MR (Measles Rubella)
View more

Logo biofarma

Call Center 1500810

Head Office

Jl. Pasteur No. 28, Bandung 40161,
Jawa Barat Indonesia
+62 22-2033755
+62 22 - 2041306
mail@biofarma.co.id

Breeding Facility Bio Farma

Jl. Kolonel Masturi Kav 10. Desa Kertawangi kec. Cisarua
Jawa Barat

Bio Farma Representative Office

Gd. Pakarti centre Lantai 7
Jln. Tanah Abang 3 no.23-27
Jakarta Pusat

Information

  • Good Corporate Governance
  • Our Procurement
  • FAQ
  • Vaccine Production
  • Your Career

 

  • Contact Us
  • E-PPID
  • Announcement
  • Media Release

Quick Links

  • Portal BUMN-Bio
  • Kemenkes RI
Copyright © 2026. All Rights Reserved by Bio Farma

Change Language

EN
  • About Us
    • Company Profile
      • Company Profile
      • PT Bio Farma (Persero)
      • Kimia Farma Tbk (KAEF)
      • Indofarma Tbk (INAF)
      • PT INUKI (Persero)
    • History
    • Management
      • Commisioners
      • Directors
    • Research & Development
    • Our Achievement
      • Awards
      • Certification
    • Report
      • Annual Report
      • Sustainability
  • Product & Services
    • Our Distribution
    • Product & Services
      • Life Sciences
      • Providers of Health Services & Products
      • Trade, Distribution of Medicines & Medical Devices
    • Immunization Services
    • Cervical Cancer Screening Service
    • FAQ
  • Media & Information
    • News
      • All News
      • Global Roles
      • Products & Services
      • CSR
    • Health Articles
    • Health FAQ
    • Our Procurement
  • Corporation
    • Good Corporate Governance
    • Our Commitment
    • CSR
    • LHKPN
      • Lapor
  • Career
    • Career
    • Recruitment
  • PPID
  • Contact Us
  • Follow us
Change Language
  • Flag Indonesia ID
  • Flag English EN